Loomis, Sayles & Company’s Orthofix Medical OFIX Stock Holding History

Loomis, Sayles & Company’s Portfolio OFIX Stock Details OFIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-302	Closed	-$17K	–	931
2018 Q2	$17K	Hold	302	–	–	﹤0.01%	774
2018 Q1	$18K	Sell	302 -289	-49%	-$16.2K	﹤0.01%	780
2017 Q4	$32K	Buy	591 +102	+21%	+$5.29K	﹤0.01%	689
2017 Q3	$23K	Buy	489 +63	+15%	+$2.97K	﹤0.01%	748
2017 Q2	$20K	Sell	426 -361	-46%	-$15K	﹤0.01%	763
2017 Q1	$30K	Buy	787 +59	+8%	+$2.18K	﹤0.01%	701
2016 Q4	$26K	Buy	+728	New	+$27.6K	﹤0.01%	738

Other funds holding OFIX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Loomis, Sayles & Company's OFIX Position: Q3 2018 in Review

Loomis, Sayles & Company sold out of Orthofix Medical (OFIX) in Q3 2018, closing a stake of 302 shares — an estimated $17K sold.

Loomis, Sayles & Company first reported a position in OFIX in Q4 2016 and held it in 7 quarters. The position peaked at $32K in Q4 2017. 162 funds tracked by Wall St. Rank hold OFIX as of Q3 2018.

Loomis, Sayles & Company reported no remaining Orthofix Medical position as of Q3 2018 after selling out during the quarter.
Loomis, Sayles & Company sold 302 Orthofix Medical shares in Q3 2018, an estimated $17K.
Loomis, Sayles & Company first reported a position in Orthofix Medical in Q4 2016 and held it in 7 quarters.
Loomis, Sayles & Company's Orthofix Medical position peaked at $32K in Q4 2017.
162 funds tracked by Wall St. Rank held Orthofix Medical as of Q3 2018.

Based on Loomis, Sayles & Company's 13F filing for Q3 2018, filed 13 Nov 2018.